MAPT and Alzheimer disease: We and others showed recently that increased CSF sTREM2 levels are associated with higher levels of p-tau in early phases of sporadic AD (Suarez-Calvet et al, 2019), and mediate Aβ-related p-tau increases in earliest Aβ fibrillization (Biel et al, 2023).